Can chemotherapy and radiation accelerate cancer progression if they don't work?

What is chemotherapy?

Chemotherapy is a therapeutic way to use chemical drugs to kill tumor cells, inhibit their growth and reproduction, and promote their differentiation. It is a systemic treatment that has therapeutic effects on primary foci, metastatic foci, and subclinical metastatic foci.

The disadvantage is the poor selectivity of chemotherapeutic drugs, in the therapeutic effect, often appear different degrees of toxic side effects; chemotherapy process of physical debility, depression, sweating, white blood cells and platelets drop, or even red blood cells, blood pigment drop ensue, and even force patients to stop treatment, the use of traditional Chinese medicine and chemotherapy with the treatment can be effective in eliminating these toxic side effects, at the same time, with chemotherapy to form a synergistic effect, increase the chemotherapy, and the chemotherapy can be effective. The chemotherapy can effectively eliminate these toxic side effects, and at the same time form a synergistic effect with the chemotherapy, increasing the therapeutic effect of chemotherapy.

What is radiotherapy?

Radiotherapy is one of the three major treatments for cancer. It is a therapeutic method of irradiating tumors with various kinds of radio

lines of different energies to inhibit and kill cancer cells. Radiotherapy can be used alone or in conjunction with surgery and chemotherapy as part of a comprehensive treatment to

improve the cure rate of cancer. A period of radiotherapy before surgery can reduce the size of tumor

somewhat, and then it can make the original inoperable patients strive for the opportunity of surgery. In the case of advanced cancer, palliative radiotherapy can be used to relieve pressure and pain.

Radiotherapy can be divided into radical radiotherapy and palliative radiotherapy. The former has a larger dose and more thorough irradiation, and is suitable for earlier and some advanced patients to eliminate primary

foci, possible residual foci after surgery, and certain metastatic foci. The latter is indicated for advanced patients

and is mostly a stopgap measure. Doses are given as tolerated to improve symptoms, reduce

pain, and prolong life. Individuals can also achieve radical results.

The doctor determines the total dose

according to the nature of the tumor, its location, the stage of the disease and the general condition. The total dose is distributed into 20 to 30 sessions, which are illuminated over a period of 4-6 weeks. After accurate

positioning, markings are drawn on the body surface and irradiated through the body surface to the tumor site. Therefore, do not scrub off the frames and other positioning marks drawn on the body surface

.